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Phenomenon in England
Elisabeth J. Vargo* and Andrea Petróczi
Pharmacy and Chemistry, School of Life Sciences, Kingston University, Surrey, UK
The non-medical use of prescription medication for the pursuit of increasing cognitive
and intellectual capacities (defined neuroenhancement) has received growing attention
from the scientific community and policymakers alike. To date, limited qualitative data
exist exploring the nature of the phenomenon, especially as a potentially emerging
trend among university students in England. Existing American literature suggests
that students believe that neuroenhancement helps the individual to maximize his/her
time, consenting a suitable balance between work and leisure. Students’ motivation
to experiment with neuroenhancement appears to be more in line with a need to
regulate emotions surrounding study/work settings than to actually improve cognitive
abilities beyond normal levels. This study aimed to qualitatively explore representations,
motivations, beliefs, and consumption styles of a cohort of university student users
residing in England. Through snowball sampling, 13 informants were contacted and
interviewed regarding their experience with neuroenhancers. Narrations were analyzed
and interpreted using qualitative analysis software and Grounded Theory methodology.
Participants belonged to a broad variety of university courses and were predominantly
habitual consumers of modafinil. Neuroenhancers were acquired either through friends
or via the Internet. Motivations regarded the need to “catch up” and be on par with
high achieving students. The entire cohort had previously experimented with other
psychotropic substances. Synthetic compounds in particular were believed to be
“gateway” drugs to using neuroenhancers. Experimentation with neuroenhancement
can be seen as a self-governing strategy aimed at achieving continued focused
productivity. Participants acknowledged sustainable benefits in neuroenhancement
as it optimized work performance. The majority of the cohort also contemplated
the possibility of using these drugs in the future once they entered the workforce.
Neuroenhancing drug users expressed “situated morality,” differentiating between using
these substances for assessments (exams) or during revisions, finding only the former
as an immoral conduct. In the present scenario, it appears that neuroenhancement
is practiced by small numbers of students. Nonetheless, the instrumental views of
psychotropic substances held by many young adults and the globalization of these
practices make the normalization of neuroenhancement a plausible possibility of the
future.
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INTRODUCTION
Humanity has attempted to increase cognitive ability since
very early in history. In ancient Greece, rosemary twigs were
placed in scholars’ hair with the hope to improve memory
(Cakic, 2009). Traditional Chinese medicine has developed
over thousands of years formulas reputed to improve cognitive
abilities and concentration (Howes and Houghton, 2003).
Today, the psychopharmaceuticalization of society (Goodman
et al., 1996) has introduced prescription medications (modafinil,
methylphenidate, phenethylamines, etc.) which can be used to
increase cognitive performance in individuals suffering from
mental health conditions such as narcolepsy, attention deficit
disorders and shift work sleep disorder (Greely et al., 2008;
Farah et al., 2014). Practices involving the non-medical use of
such medications on the part of healthy individuals have been
coined with the term pharmacological neuroenhancement, and
have received growing attention on the part of the scientific
community (Quednow, 2010; Repantis et al., 2010; Wolff and
Brand, 2013).
In particular, an area of scientific interest resides in the use
of these medications on the part of university students (Hall
et al., 2005; Varga, 2012). Although it is still unclear if this
trend is actually growing within the young adult population
(Partridge et al., 2011; Ragan et al., 2013) or if it is a facet
of a generalized aptitude on the part of western cultures to
“medicalize” mental life (Coveney et al., 2012), ethical and
policymaking issues still arise from this phenomenon. Besides
whether neuroenhancement constitutes cheating (Lucke, 2012;
Bell et al., 2013), it can also be hypothesized that these
practices may become normalized, considering their appeal to
younger adults entering the workforce (Wolff et al., 2014).
If this population reputes these substances as instrumental
to reach the full potential of their cognitive capacities, they
may very well prolong neuroenhancement later in their life.
Neuroenhancement already appears to be more or less prevalent
in working populations (Maher, 2008; Banjo et al., 2010;
Racine and Forlini, 2010; Wiegel et al., 2015). In a previous
study, we found that socio-economic factors related to the
competitiveness of the job market and preoccupations regarding
occupational stability promoted a willingness to experiment with
neuroenhancers (Vargo et al., 2014).
Neuroenhancement’s actual efficacy in improving intellectual
performance in healthy populations is yet to be established
(Farah et al., 2014) and has not been proven safe (Maier and
Schaub, 2015). The addiction risk posed by these drugs is
still in debate but nonetheless, concerning side effects such as
psychosis, insomnia, and irritability may arise from the use of
these substances (Hysek et al., 2014).
Prevalence
According to survey data, significant portions (between 5
and 35%) of the North American student population utilize
prescription medication to aid their cognitive abilities (Wilens
et al., 2008). In the U. S., greater prevalence of use has been
found among white male students, and members of fraternities
and sororities (Hall et al., 2005; McCabe et al., 2005). Prevalence
rates in Europe remain unclear, although they appear to be lower
compared to North America (Maier and Schaub, 2015). In a
study surveying UK students, less than 10% reported lifetime
prevalence, but one third expressed an interest in experimenting
with neuroenhancement (Singh et al., 2014). According to
authors, low prevalence and high interest among British students
could be moderated by the scarce availability of neuroenhancers
(Singh et al., 2014).
It has also been debated that in the U. S., the endemic
prescription of Ritalin to minors in the 1990s has contributed
to the widespread use of prescription stimulants among young
adults in higher education (Conrad and Potter, 2000; Loe,
2008). Although this interpretation is coherent within the North
American context, it does not justify the apparent growing
popularity of these practices in European contexts. Prescriptions
to young children of these medications are less common in the
UK, and have only risen in the last decade (Southall, 2007).
User Characteristics and Motives
Individuals who use neuroenhancers appear to have lower levels
of self-efficacy and score higher on neuroticism scales (Maier and
Schaub, 2015). They are also more likely to abuse other legal and
illegal substances for self-medication (Novak et al., 2007; Singh
et al., 2014). According to Quintero et al. (2006), the unprescribed
use of medications for physical, social and psychological needs on
the part of healthy young adults is part of broader normalization
processes which involve the medicalization of a variety of
states of being. College students view prescription drugs as a
safer and more socially acceptable alternative to using “harder”
drugs (Quintero et al., 2006; DeSantis and Hane, 2010). In
this prospect, the self-medication hypothesis has been proposed
by several authors as an explanation to these contemporary
trends. Ford and Schroeder (2008) have found that students
reporting higher levels of depression were more likely to
experiment with prescription stimulants. Wolff and Brand (2013)
found that university students view neuroenhancement as an
acceptable means to cope with stress related to scholastic
demands.
Qualitative research exploring neuroenhancement has
evidenced that this practice is embedded in a multifaceted life
characterized by high demands (Hildt et al., 2014). Students
believe that neuroenhancement helps the individual maximize
his/her time, thus consenting a suitable balance between work
and leisure (Hildt et al., 2014). Moreover, Vrecko (2013) argues
that students’ motivation to experiment with neuroenhancement
is more in line with the need to regulate emotions (increase
enjoyment, interestedness, and drivenness) than to its actual
capacity of increasing cognitive performance. According
to de Souza (2015), biomedical discourses characteristic of
contemporary society dominate students’ beliefs in regards
to the efficacy of neuroenhancement. The body-as-machine
metaphor is used to interpret the problems of college life,
and pharmaceutical drugs are viewed as a quick fix to the
“mechanical” problems of lack of time, motivation and
stress (de Souza, 2015). This cultural representation is
amplified when exploring the views of students who have
obtained prescriptions for neuroenhancers: the boundaries
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between treatment and enhancement appear blurred, and
prescription is used as a form of legitimization (Petersen et al.,
2015a).
Aims and Objectives
Aims and objectives of the present study regarded the
investigation of motivations, beliefs and attitudes tied to
neuroenhancement on the part of university students, using
qualitative and ethnographic techniques that give value to the
individuals’ subjective experience. England is characterized by
different sociocultural factors than the North American context,
thus it is relevant to provide a qualitative account of the
neuroenhancement phenomenon within this context. In the UK,
Ritalin (methylphenidate) is a Class B drug while modafinil
is unclassified and more easily purchasable via the Internet
(Advisory Council on the Misuse of Drugs [ACMD], 2015).
Moreover, it is to be noted that the students participating
in this study belong to the first wave of students who are
paying full tuition fees as of September 2012 (£9,000 a year),
which amount for increased pressure to do well in their
studies to secure a good job upon graduation. It is to be
noted that the present study does not aim to provide data
representative of the entire population of neuroenhancement
users, or of the subpopulation of University students in England
using these types of enhancers. Moreover, our intent revolves
around the need to explore psychosocial variables involving
networks of users, outlining their specificities and identifying
those elements attributable to a more generalized drug using
culture.
Research Sample
For the purpose of this study, 13 informants were approached
through ethnographic methodology, using snow-ball sampling
(Fountain, 2000). The inclusion criterion was having used a
neuroenhancer at least once without a medical prescription. Once
key figures were contacted, these individuals were asked to help
find more participants who belonged to the same social network
of users.
Participants belonged to a small age range varying between
21 and 24 years old (M = 22.5 ± 0.9 years). The sample
contained more males (n = 8) than females (n = 5), reflecting
survey results which evidence a propensity on the part of male
students to experiment with these drugs (Hall et al., 2005;
Vargo et al., 2014). The entire sample possessed a bachelor’s
degree and three participants were pursuing a postgraduate
degree. Subject studied during undergraduate studies varied
greatly, with four participants in the social sciences, four in
computer and engineering and five in biology and medicine.
Again reflecting survey results (McCabe et al., 2005), nine
participants were white British, two were white Canadian and
two were Pakistani. Within the sample, five participants had
experimented with neuroenhancing drugs less than 10 times
(“sporadic” users) while eight had used them habitually for a
limited or extended period of time (“habitual” users). Figure 1
depicts the sociogram of the study sample and the snow-ball
sampling process.
MATERIALS AND METHODS
Qualitative research plays a fundamental role in the
comprehension of the psychotropic drug use phenomenon
(Fountain, 2000). Ethnographic research can provide qualitative
information that not only contributes to a clearer understanding
of new drug trends, but can also provide a term of comparison
for quantitative research designs.
The methodologies utilized in this study are characterized by
flexible data collection and an unstructured initial hypothesis.
GT methodology and the Life-Story interview technique (Strauss
and Corbin, 1990; Atkinson, 1998) permit the same themes
proposed by the participants to become object of interpretation,
maintaining the original linguistic code adopted by the sample.
Through the Life-Story interview, participants are free to
tell their own “story” in regards to neuroenhancement use.
Subsequently, associations between thematic categories emerging
from GT methodology determine the creation of a “single”
storyline (Strauss and Corbin, 1990) which narrates the sample’s
experience and relationship with neuroenhancement. Coherently
to a constructionist approach which interprets reality as resulting
from a shared social construction (Kelly, 2003), it was chosen to
interpret the research samples’ narrations as “sense-making” of
the investigated phenomenon. Considering the debates on the
morality of neuroenhancement (Goodman, 2010) and that the
non-medical use of some neuroenhancers (e.g., Ritalin) is illegal,
it was acknowledged that participants would show resistance
upon the request to share their personal experiences. Using a non-
judgemental attitude and a tolerant approach, it was possible to
overcome the suspicion and resistance that people would usually
enact when prompted regarding their illicit conducts (Lambert,
1990).
Procedure
Participant recruitment followed the snowball sampling method.
This technique assumes that the members of a social network are
able to identify better than the researcher potential participants
and are better informed in regards to the practices the researcher
wishes to investigate (Lambert, 1990). Neuroenhancing substance
users (participants 1, 2, 5, 8, and 13 in Figure 1) were
initially identified (from previous studies and the researcher’s
social network) as key informants for the subsequent snow-ball
sampling process. During data collection, the researcher took
notes of the snow-balling process to aid the interpretation of
results.
In agreement with the key informants, potential participants
were contacted directly by the researcher and details regarding
the study’s objectives and procedure were first handedly described
to them. Once the potential participant agreed to participate in
the study, a meeting was arranged to carry out the interview.
The setting of the interviews was a quiet and private area,
where the interviewee could feel comfortable and at ease. As
suggested by Atkinson (1998), participants were told before the
actual interview to think about and try to recall significant events
of the past and present which they found relevant to their
experience with neuroenhancement. This would help the sense-
making process and avoid that the interviewee presents a mere list
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FIGURE 1 | Sociogram of the study population. Numbers represent the order of recruitment.
of events. The aim of this type of interview is in fact to achieve an
actual story of the individual’s experience, with characters, setting,
plot, conflict, and resolution (Atkinson, 1998).
Interviews lasted approximately 45 min and were divided
into three parts, each lasting about 15 min. According to
Atkinson (1998), separating the phases of the interview helps the
participant reflect and elaborate the contents he/she wishes to
share. Each subpart was introduced by a prompt enquiring about
the interviewee’s relationship with neuroenhancement in the past,
the present, and the future.
Interviews were carried out between March 2014 and March
2015. These were audio recorded and subsequently transcribed,
omitting parts where the interviewee made reference to private
information that could endanger their anonymity (names, places,
etc.). The study was approved by the Kingston University
Faculty of Science, Engineering and Computing Research Ethics
Committee. At completion of the interview, participants were
rewarded for their time and contribution with a £20 gift voucher.
The Life-Story Interview
The Life-Story interview (Atkinson, 1998), a discoursive and
non-directed interview based on the active participation of the
research sample in the creation of an interpretation, was chosen
as our primary instrument for data collection. This interviewing
technique views the narration of the story as the creation of a
shared truth between the narrator and the listener. The story
represents a privileged form of a unique personal expression, thus
a way to access the cognitive world and representations of the
storyteller.
The Life-Story interview is relatively unstructured and based
on cooperation. The interviewer abstains from commenting or
providing opinions in regards to the participant’s conduct, and
allows the interviewee to choose which topics and subjective
experiences he/she wishes to share in relation to the interview’s
queries. In the case of the present study, three prompts were used
to develop the interview:
(1) To describe the first time they experimented with
neuroenhancement, their impressions, their beliefs before
and after this event. To describe how the substance affected
their body and their performance.
(2) The second prompt regarded the interviewee’s relationship
with neuroenhancers in the present: how did their use evolve
from the first time they experimented with them and how
the effect changed or maintained itself. The interviewee was
then asked what opinions and attitudes their friends and
family had in regards to neuroenhancement. In the case
the interviewee was unaware of their friends’ and family’s
attitudes, he/she was asked to imagine how they would react
if they found out about their conduct.
(3) The third prompt asked the participant if he/she intended
to use neuroenhancers in the future and under which
circumstances. The interviewee was asked to imagine this
hypothetical scenario, as well as what kind of motivations
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would lead to this decision. The participant was then asked if
he/she had ever used other psychotropic substances and how
they were similar or different to the neuroenhancers they had
experimented with.
These prompts aimed at collecting data regarding participants’
attitudes, beliefs, and consumption trajectories in relation to
neuroenhancement. In particular, the first question aimed at
comparing beliefs regarding neuroenhancers before and after
drug experimentation, and motivations tied to the intiation
of this conduct. The second question aimed at collecting
information regarding consumption trajectories, as well as
participants’ beliefs regarding ingroup and outgroups’ attitudes
and representations of psychotropic drug use. The third question
explored intentionality of using neuroenhancement in the future
and psychotropic drug use in general.
The life-story interview is a qualitative research method which
does not aim at confirming the presence or absence of specific
categories, but intends to collect an uncountable number of
models and meanings that permit the formulation of inductive
hypotheses. According to Atkinson (1998), historical truth is
not the main issue when assessing a story’s reliability. The
possibility of considering the story worthy of trust is more
relevant to the research process. The objective is not to measure
an objective truth, but to collect information regarding the
subjective experiences of a social event.
Grounded Theory Methodology
The goal of GT methodology is to systematically explore the
meanings that the study participants attribute to the social reality
they belong to, in order to produce “plausible interpretations”
of a process or an interaction (Creswell, 2008). The main
approach consists in a constant comparison between the different
phases of interpretation, following a circular process (Strauss
and Corbin, 1998). The starting point is a “cognitive query”
regarding a specific issue, in our case the meanings attributed to
neuroenhancement.
Through the coding process, the narrations are fragmented
and reassembled via an abstraction process. Initially, concepts
are organized in codes that are as close-fitting as possible to
the text and progressively, the categorization process promotes
the abstraction of these concepts. A code therefore, describes
a portion of the text (quotation) through a label representing
the narrative theme. Following the GT method, units are chosen
according to their groundedness (prevalence in the narrations) or
to their significance for the researcher’s theoretical elaboration
(Strauss and Corbin, 1990). The coding process is divided into
three phases: open, axial, and selective coding. These do not
follow a linear sequence but a circular one, as data and categories
are constantly compared with each other in this process.
Data Analysis
This study utilized Atlas.ti software, which is tailor-made for GT
methodology; and supports and organizes the coding procedure.
Analysis of the relationships between codes is possible through
the query tool, which analyses Boolean, logical, semantic, and
proximal links between the categories. Atlas.ti also aids the
analysis of relationships between conceptual categories and
socio-demographic or other structural variables (i.e., gender,
social network affiliation, drug used, and consumption style).
Through this software program it is also possible to visually
organize the codes emerging from the analytical process.
Figure 2 shows the conceptual map or storyline representing the
organization of the codes. This organization is dictated by the
GT methodology previously described, thus by the inductive–
deductive process which aligns the researcher’s interpretation
to the co-occurrence and groundedness of the narrations’ main
themes.
RESULTS
The narrations of our study sample presented fairly coherent
stories in regards to motivations, representations and effects
experienced. As can be observed in Figure 2, reasons behind
using neuroenhancers are semantically very similar (e.g.,
concentrate, stay awake, and focus). Regarding the type of
neuroenhancers used, eight participants had tried modafinil
(Modalert, Modavigil; a wakefulness promoting agent), two
had also tried either Ritalin or Adderall, and three participants
experimented with Adderall. Access to the prescription
medications Ritalin and Adderall was determined by the fact that
participants were in North America when experimentation with
these substances occured, or someone who had these prescribed
in North America provided them the drugs. According to the
sample, prescription medications Ritalin and Adderall were very
difficult to obtain in the UK whereas in North America, the
use of these medications was very common among university
students. No significant differences were found in regards to
the effects provoked by these different compounds, thus the
perceived effects were grouped for all three compounds.
The codification process resulted in the identification of
1593 quotations organized in 77 codes. The sample’s storytelling
was centered around explaining and justifying the reasons
behind their prescription stimulants use to improve academic
performance. The storyline elaborated from interpretation was
organized according to this recurring and preponderant theme.
Motivations Leading to
Neuroenhancement
The analysis of the sample’s narrations evidenced that an
important motivation leading to experimentation with
neuroenhancers was work management and the possibility
to intensify working sessions within limited periods of time.
Primarily, participants hoped neuroenhancement would help
them to “pull an all-nighter,” boost their concentration, energy
and motivation toward the task at hand. The need to resort
to modafinil or other neuroenhancers derived from pressing
deadlines or preoccupations with performing well.
“There are people who I was aware of, who were just working
way harder than me and weren’t taking any drugs at all. Maybe
you’re just bringing yourself up to their level by making the use of
chemicals.” Brian, aged 22.
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FIGURE 2 | Conceptual map depicting the sample’s storyline. Nodes represent the most relevant codes according to groundedness and centrality in the
interpretative process. Links represent relationships between codes.
As a matter of fact, many participants although aware of the
existence of these compounds, chose to use them during the final
year of their degree, when the pressure to outperform increased.
These participants would also actively purchase modafinil from
the Internet, driven by their need of assistance in their work
management.
Expectations relative to neuroenhancers were mainly formed
from the experiences of peers’ already using these drugs or
from the media. In general, participants would use Internet
sites (e.g., Wikipedia, Reddit) to find more information on
the effects of neuroenhancers and explore the experiences of
other users. Moreover, these students were not preoccupied with
negative outcomes and detrimental side effects: they viewed these
substances as medications and had rarely heard of negative
experiences on the part of their peers. Many students described
not having particular expectations in regards to cognitive
enhancement and described their motivation to try as determined
by situational needs.
“I didn’t really think much of it, I just took it to see if it would really
work.” Caroline, aged 21.
Moreover, a small number of participants were motivated to
try neuronhancement out of curiosity, as they belonged to social
networks of individuals who were using these drugs. Reassured
by their peers’ positive experiences and motivated by the
growing popularity of “smart drugs,” these participants usually
experimented sporadically and never acquired the substance
directly.
“To be honest, the first time I tried it, it was more because I was
bored of revising and writing the essays, rather than the fact that I
necessarily needed to focus more. I thought ‘maybe it will be easier,
maybe it’ll be more interesting, and I’ll see what it’s like’. I got it
because he was getting some anyway, so he just got me some to try.”
Brenda, aged 24.
Before experimenting with neuroenhancement, the entire
sample had tried at least one illicit substance. The most
commonly mentioned drug was cannabis, then MD/MA (or
ecstasy). Other illicit substances mentioned were cocaine, speed
(or base), MDA, hallucinogenic mushrooms, LSD, ketamine, 2C-
B, 2C-I, 2C-E, and 25I. For some, MD/MA was considered a
“gateway” drug to neuroenhancement: their initial experience
with this drug led them to change their views in regards
to synthetic compounds. After experimenting with them,
participants saw synthetic drugs as less dangerous, thus
contemplated the possibility of using them for purposes different
from entertainment. Moreover, other participants considered
themselves “drug effect explorers” or, as defined by the drug using
community, psychonauts: this term defines individuals who see
psychotropic substances as a means to explore new experiences
and new ways of relating to their environment. Drugs can be used
rationally to enhance one’s life experiences and are considered
privileged keys to access different levels of consciousness.
Experimentation with
Neuroenhancement
The majority of participants had a positive experience with
neuroenhancing drugs. Actual effects met their expectations and
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the substance assisted them in meeting their goals. In line with
their expectations, participants felt more awake and focused,
“on the ball” and more interested in their work. Interestingly,
many acknowledged the possibility of experiencing a “placebo
effect.” Although it was recognized that neuroenhancers did not
actually change the way participants thought or that they actually
“created” motivation, effectively concentrating and focusing on
their tasks provided them with a sense of enjoyment. In this sense,
it can be stated that neuroenhancement provides an experience
that in general, is rewarding for the user both at a cognitive
as at an affective level. As would be expected, participants who
described the experience as pleasurable, tended to intensify and
habitually use neuroenhancers.
“It was me on a good day, it wasn’t any better than me on a good
day, it was me on the best day I could ever have.” Amber, aged 22.
“I don’t even know why, because I know I could do without them,
it kind of makes me feel more confident. If they’re there, I know I
could have a good day of work if I needed to but I could do without
it.” Mohammed, aged 22.
In general, participants described a primary effect that would
last 5–8 h, and a feeling of being awake that would prolong
itself for several more hours. The outcomes of neuroenhancement
were reputed similar to those felt when drinking coffee, although
participants recognized distinct differences in the capacity to
remain focused and concentrated. Effects depended on the
dosage taken, and many participants experimented with different
amounts to achieve the desired effect. Taking half a pill for
example, provided alertness while taking a full pill would provide
more noticeable effects, both physically and psychologically. In
particular, a full pill would give a “buzz,” a heart rush and a
significant change in their motivational drive. Some participants
described the “rush” as similar to that experienced from MD/MA
or cocaine but to a lighter extent.
Consumption patterns varied widely, with some participants
taking just a quarter of a pill sporadically to others who would
take several pills during a single session. Intense use, such as using
the substance for several days in a row, was described as extremely
tiring for the body, and some believed that this conduct led to
habituation. The majority of participants would take a half or full
pill in the morning to take advantage of the effect during the day.
Some would take a pill in the evening to work throughout the
night. This modality usually resulted in a negative experience,
as it affected sleeping patterns. Moreover, the majority of
participants would use neuroenhancing substances for study
revisions or to complete coursework (writing essays, project
assignments). Often other stimulants were used simultaneously,
such as coffee or caffeine pills, and energy drinks. Some, in
particular males, had experimented with these substances in
different contexts than solitary studying, and had neuroenhanced
at work, for job interviews, during work out sessions, when
clubbing or during examinations.
“And then I also took half before I went for an exam. To be honest
that was one of the best effects I had out of it... I think it definitely
improved my memory in that case.” Toby, aged 22.
In general, participants did not complain of particular side
effects although the most frequently mentioned was insomnia.
This side effect mainly concerned those using modafinil. When
experiencing unwelcomed side-effects, participants adjusted
their consumption style in order to avoid this side effect,
or utilized other psychotropic substances (cannabis) to relieve
their difficulty sleeping. A minority of the sample complained
that using the drug when living a state of stressfulness
would worsen the feeling and provoke panic and excessive
worrying. Again, participants reported that they adjusted
their consumption pattern in order to control this side
effect.
Distractions from work would also provoke a state of
uneasiness and distress. Some participants described being
annoyed by distractions and avoiding social interactions. This
feeling though depended on the intentionality of the user,
as participants who were using neuroenhancers in work
contexts contrarily described enjoying social interactions as
they improved their communication style and eloquence.
Participants described having a “craving” or “fixating” on
doing something when under the effect of neuroenhancers,
and for this reason keeping focused on the task at hand was
important. This feeling would manifest itself in chain smoking,
reordering objects or intense “Internet surfing.” Regarding
physical side effects, some participants described having heart
palpitations at the initial stages, loss of appetite and increase in
thirst.
A duality emerged from the narrations in regards to
the addictive quality of neuroenhancers. On one side,
participants were informed that these substances were
not physically addictive, and this was seen as a reassuring
characteristic. On the other, some participants were
preoccupied with psychological dependence, as they considered
the possibility after continued use, of having to rely on
these substances to carry out their work in an effective
manner.
“Thinking about what I’ve said it sounds like I’m addicted to them
or something. The language that’s being used, I want to take it once
a week, adding it to your daily life sounds quite similar to someone
addicted to a specific drug, like coke, I’d only take it during the week
ends. That’s how it starts, and then you’re taking it all the time.”
Paul, aged 24.
Participants viewed neuroenhancement as very different
from using other psychotropic substances. The effects of
illicit substances were seen as more intense and involving
the whole body. Neuroenhancement on the other hand was
perceived as more “psychological,” and not as physiologically
overwhelming. Neuroenhancing drugs did not manifest any
noticeable physical effects, whereas other drugs were much
more visible. Many participants underlined the fact that
neuroenhancers did not provoke particular negative effects once
they wore off, contrarily to other drugs such as cocaine or
MD/MA which are characterized by a “come down.” Moreover,
neuroenhancement was seen as significantly different from other
illicit drugs as the former were used for functional reasons and
not recreationally.
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Attitudes of Participants’ Social
Networks
Participants described belonging to social networks where the
majority of peers did not use neuroenhancers. On the other
hand, the three participants who had also experimented with
neuroenhancement in North America described a different
scenario where these substances were widely used. The cohort
believed that non-users were better organized, more focused
and therefore did not need to use neuroenhancers for their
studies. According to participants, people who did not use
neuroenhancers made this decision based on moral grounds,
as they were against using drugs in general. Many participants
shared that some of their peers and friends were curious
about their experience with these substances. They believed that
given the opportunity, more students would experiment with
neuroenhancers.
“Friends opinions usually start off negative just because they say you
don’t know what it is, you go online. Until you don’t explain to them
or you show them, then they’re like ‘Oh my god, I want to try some.’
When they learn about it, their opinion seems to change.” Claire,
aged 21.
The sample expressed concerns in regards to general attitudes
which believed neuroenhancement was a form of cheating.
Participants were worried that their choice might invalidate their
achievements or that they would be kicked out of university
or fired if they were exposed. In particular, habitual users
discussed more of this topic, yet believed that this moral
approach was inappropriate. Neuroenhancement was said to be
the same as drinking coffee during studying sessions and did
not change an individual’s capabilities. Some believed that using
neuroenhancers during exams would be a form of cheating; using
them during revisions was not unethical.
“It’s kind of giving you an unfair advantage but then at the same
time there are people who I was aware of, who were just working
way harder than me and weren’t taking any drugs at all.” John,
aged 23.
Participants stressed that in comparison to individuals who
were more capable at focusing and managing their commitments,
they were not gaining an unfair advantage but were contrarily
“catching up.” When considering peers who were as stressed or as
under pressure as them, participants saw that neuroenhancement
was providing them an unfair advantage. Nonetheless, the fact
that these substances were widely known and easily purchasable
on the Internet provided a justification to their conduct.
With very few exceptions who felt that their caregivers
completely trusted their judgment and decisions, the sample
believed that family members would disapprove of their
experimentation with neuroenhancers. In general, family
members were believed to have negative attitudes toward
drugs, and neuroenhancers would be seen as belonging to the
same category. The sample believed their family saw drugs as
dangerous and taking drugs to study would be perceived as
“crazy.” They would usually not discuss these experiences with
their parents or siblings, as they were preoccupied with raising
concerns.
Intentionality to Use Neuroenhancement
in the Future
The study sample believed that overall, neuroenhancement had
a positive impact on their work commitments. In particular, it
helped them stay awake and complete their work in restrained
periods of time. Nonetheless, they believed that it did not “add”
anything to their actual capabilities, and some were convinced
that having better management skills would have provided the
same contribution as neuroenhancement.
“If I was getting behind work and I felt like I needed to catch up, if I
felt I needed to get a lot of work done in a short period of time, there
was a deadline moving, or if people around me start taking them I
might feel maybe I should take them as well.” Peter, aged 22.
With the exception of two participants, the whole cohort
contemplated the possibility of using neuroenhancers in
the future. The reasons behind this intentionality were the
effectiveness of these substances and their affordable price. The
possibility of using neuroenhancers was considered situation
dependent, as participants believed that neuroenhancement
was useful in times of intense stress and responsibilities.
Some participants still possessed a “stash” of these drugs
in case of need. As can be seen in Figure 2, participants
viewed the possibility of neuroenhancing again as associated
to their postgraduate studies or to a future job characterized
by tight deadlines and individual projects. The possibility of
being fired or getting in trouble in a work environment
due to this practice was considered a deterrent from further
experimentation.
“There’s a big difference between taking it at university and taking it
at work because work is the rest of your life, and having to take drugs
to get through the rest of your life sounds terrible.” Brian, aged 23.
Moreover, the fear of “losing control” over one’s drug using
was considered another deterrent to further experimentation.
Participants also contemplated the possibility of using other
neuroenhancing drugs. According to their narrations, many
other neuroenhancing drugs are available via the Internet and
web forums provide valuable information on their efficacy. An
example of alternative neuroenhancing methods is “stacking,”
implying the use of cocktails of substances to reach optimal levels
of alertness and concentration.
DISCUSSION
The study sample’s motivations to neuroenhance resided in their
need to “catch up” and cope with their work related demands,
in line with previous qualitative literature on the phenomenon
(Repantis et al., 2010; Coveney, 2011; Vrecko, 2013). These
findings also appear to be aligned with quantitative studies
showing a propensity on the part of lower achieving students to
use neuroenhancement (Benson et al., 2015).
Neuroenhancement was usually a solitary practice integrated
with the way participants preferred to study. Modafinil was the
most widely used neuroenhancer, as it was easily purchasable
via the Internet and posed no legal consequences. In line with
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Singh et al.’s (2014) results, prescription medications Ritalin and
Adderall appeared to be more difficult to obtain within the UK.
The study’s participants who had tried these medications accessed
them through individuals in their social network that had
prescriptions (which were usually obtained in North America).
The decision to experiment with neuroenhancing drugs was
also determined by their apparent growing popularity and
by the attention they receive on Internet forums and the
media. Participants believed these substances were safe, being
medications. Moreover, their peers’ experiences with these drugs
were generally positive, leading to a willingness on the part of
some participants to try these substances without any specific
need to “enhance.” In our sample, willingness to purchase
modafinil via the Internet was associated with habitual use and
intentionality to use neuroenhancers in the future.
Previous experiences with various psychotropic drugs led to
a propensity to further experiment with neuroenhancement,
confirming findings from previous literature (Novak et al., 2007).
In particular, participants had broadly experimented with several
synthetic substances which they conceived as a “gateway” to
using other synthetic compounds for work related purposes.
This representation confirms the idea that psychotropic drugs
are integrated in western cultures, and seen as instrumental
for the adaptation to modern life (Müller and Schumann,
2011). Moreover, the sample often practiced polysubstance use
by simultaneously ingesting neuroenhancers with other legal
stimulants to heighten their effect. Other psychotropic drugs
such as cannabis were used by some participants to relieve
the side effects caused by modafinil use. The instrumental
view of psychoactive substances is further evidenced by the
“psychonautical” culture (where drug experimentation is part of
existential investigation) emerging from the sample’s narrations.
This theme originating from the psychedelic subcultures of
the 1960’s now appears to be a cultural value characterizing
contemporary youth cultures (Schifano et al., 2003; O’Brien et al.,
2015).
The sample’s experience with neuroenhancement led them
to believe that these substances couldn’t actually change their
cognitive and intellectual capacities, yet the majority continued
their use and found them to be useful for their work performance.
Although potential users believe prescription stimulants can
improve cognitive abilities, research has shown little evidence
of significant improvement in healthy populations. On the
contrary, it is suggested that neuroenhancers may have a greater
impact on mood and perceived motivation (Ilieva and Farah,
2013). Differently from legal stimulants such as coffee or energy
drinks, neuroenhancers not only promoted wakefulness but the
possibility “to not worry about anything except for the task at
hand.” According to the narrations, their efficacy resided in
helping them achieve a sense of focused productivity which
fulfilled their motivational goals, consequently providing for the
majority a sense of enjoyment. In this sense, neuroenhancers are
not strictly viewed as a means to push the boundaries of what is
possible for the individual but as a way to normalize performance
during abnormal circumstances (Coveney, 2011).
Participants were aware of side effects consequential to
neuroenhancement use and abuse. They demonstrated to be
“rational” drug users by adopting strategies to control their use
patterns and regulate consumption (Zinberg, 1984). These varied
from reducing the amount of substance ingested to adjusting
their times of consumption in order to avoid insomnia, which was
the most frequent side effect mentioned by the sample. Moreover,
the majority of participants viewed the use of neuroenhancement
as circumstantial to specific moments of their existence (i.e.,
during periods of intense stress). Nonetheless, a dichotomy
emerged from the narrations regarding the addictiveness of
neuroenhancers. On one hand, these were not considered to
be addictive, and this constituted a reassurance regarding their
safety. On the other, some participants had experience of peers’
abuse and reliance on these substances, thus acknowledged the
possibility of becoming “psychologically” addicted. Prevention
and harm reduction strategies should address this ambiguity
and better inform public knowledge regarding the meaning
and psychological harm of addiction in its various forms (Ross
et al., 2010). Moreover, research has demonstrated that students
who neuroenhance adopt at-risk conducts which could lead to
addiction (Hildt et al., 2015).
Another concern arising from the sample’s narrations
regarded the morality of their conduct. Participants did
not entirely believe that neuroenhancement constituted
cheating, especially when carried out for revision or coursework
completion. Using neuroenhancement for an exam or job
interview on the other hand was reputed cheating. It appears
that this conduct is practiced following a contextualized or
situated morality. Similar to previous findings (Vargo et al.,
2014), zero-sum situations elicit moral disagreement regardless
of enhancement utilized. The need to enhance is a response to
contextual demands linked to ecological pressures, evidencing
its functional role in the daily routines of users. Attitudes
of the general population toward neuroenhancement were
perceived as negative. Participants believed that if their conduct
were exposed, they would be fired or their achievements
would be invalidated. Due to the fear of society’s negative
judgement, participants held conflicting norms in relation to
using medications for competitive needs, similarly to what
has been found in athlete populations in relation to doping
(Bloodworth and McNamee, 2010). Considering what has been
learned from drug prohibition and anti-doping (Kayser and
Smith, 2008), repression inevitably leads to a submersion of
the phenomenon and consequently to increased difficulties
when public health would aim at addressing the issue. Under
a harm reductionist perspective, it would be important to
not address this phenomenon using moralistic and purely
bioethical paradigms (Ketchum, 2013), as these approaches
produce social deviance and further harms, especially when
neuroenhancing compounds are used for self-medication
(Quintero and Nichter, 2011; Levinson and McKinney,
2013).
Beliefs regarding the effectiveness of neuroenhancing drugs
led the majority of participants to imagine using these substances
in the future. In this study, attitudes of non-users toward
neuroenhancement appear to be negative. If the functionality of
these drugs for users’ lives and goals emerge in other quantitative
and qualitative studies in different contexts, a normalization
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of this conduct in future years can be hypothesized (Benanti,
2010). Our cohort resided in England but those who had
also experienced with these drugs in North America described
distinct differences in regards to the availability and popularity
of neuroenhancement drugs. When also considering the notable
attention these practices receive from the media (Partridge
et al., 2011), a process of cultural accommodation and
globalization of these practices is possible in the years to
come.
Neuroenhancement seems to be an adaptation to work-
hard play-hard lifestyles, as well as to the competitiveness
of contemporary higher education. Borrowing from Foucault’s
(1985) concepts relative to the Technologies of the Self, drug
use conducts have an adaptive and functional role within the
environmental setting in which they are carried out. Prescription
stimulants can be seen as a strategy to govern the self, not just
in relation to quantifiable results, such as grades or amount
of work done, but also in relation to the affective experience
of working hard and feeling on par with high achievers.
Considering the evidence available and the absence of studies
outside controlled laboratory experiments objectively verifying
the efficacy of cognitive enhancers for healthy populations, it
is difficult to confidently state in a quantifiable and objective
manner that users are or are not actually enhancing their
cognitive performance. Participants’ narrations nonetheless
speak of advantages in terms of fulfilled accomplishments and
focused productivity, and not in terms of quantifiable differences
in their learning abilities. Although neuroenhancement drug
users hold representations of cognitive enhancers as drugs
capable of enhancing cognitive and intellectual abilities, they
appear to be motivated to use these substances to keep up
with academic demands, and not to push the limits of their
abilities (i.e., being smarter or knowing more). Thus, their
use is tied to the need to comply with and readjust their
work performance to meet the day-to-day demands of their
academic courses. Neuroenhancement can be seen as fulfilling
efficacies both at a social as at a cultural level (Petersen et al.,
2015b).
Outlining an articulate description of the phenomenon
which considers the complexity of social attitudes, motivations,
beliefs, and consumption styles seems coherent with the real-
world applications of the findings of this study. Nonetheless,
limitations reside in the small sample size and in the absence
of quantitative information regarding personality and intra-
individual variables. A limitation that can be identified in
the methodology used in this study regards the risk of not
fully satisfying theoretical saturation through the recruitment
process. The snowball sampling process was in fact interrupted
as participants were not able to identify more users and it
was not possible to expand the study’s cohort. However, in
qualitative research sufficiency of sample size is measured by
depth of data rather than frequencies (O’Reilly and Parker, 2012).
The high coherence identified in the participants’ narrations
reassures that the data are reliable and relevant to understanding
academic neuroenhancement in the English context. It can be
hypothesized that the hidden population of neuroenhancing
drug users is very contained in the geographic area assessed,
and this may have been reflected in the snow-ball sampling
process.
Moreover, a re-analysis of the narrations could involve
more than one researcher in the coding process. Further
investigation of this phenomenon could explore and compare
the representations of young adults using neuroenhancement
in work related contexts, or in different geographical
settings. Future research should also investigate the neuro-
biological effects neuroenhancing compounds produce
on healthy individuals (Ilieva and Farah, 2013) as well
as how perceived effectiveness and intrinsic motivation
influence initiation and patterns of use (Ilieva and Farah,
2015).
CONCLUSION
Our intent was to provide theoretical hypotheses that
could contribute to the understanding of the phenomenon
and promote effective preventive strategies. The sample
used neuroenhancing substances to satisfy adaptive needs
related to their work and academic demands. Substances
were acquired from unsafe sources and many participants
showed a willingness to resort to these compounds if they
encountered stressful work situations in the future. These
aspects should be taken into consideration in future harm
reduction interventions. Understanding how an individual
belonging to a specific social category constructs the usefulness
of a psychotropic substance, and comprehending which
motivations and beliefs lead him to experiment with it, are
vital for the elaboration of appropriate and effective harm
prevention.
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